Algo version: 0.98b
Charmacy Pharmaceutical is listed at the HKSE Exchange
Charmacy Pharmaceutical [2289.HK]
HKSE Sector: Healthcare Industry:Medical Distribution

Is Charmacy Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Charmacy Pharmaceutical pays dividends. Last time was Wednesday 10th of July 2024 where the investors holding the stock on Wednesday 22nd of May 2024 were paid HKD0.32977 per share. Over the last 10 times between 2016 and 2024, Charmacy Pharmaceutical has paid HKD2.90318 with an average of HKD0.29 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Charmacy Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD7.05, you would have made a profit of HKD1.290 per share or 18.30%

No, the average daily trading liquidity for Charmacy Pharmaceutical is HKD44 306 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Charmacy Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company has a very low net profit margin of 1.17%, which is challenging.

We have calculated the inflation risk for Charmacy Pharmaceutical to be medium [0.65 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.